New to Meducation?
Sign up
Already signed up? Log In
view moderators

BreastNeoplasms

Category

0
1
16

BCUTT2 2007 | Treatment of HER2-Positive Early Breast Cancer

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Treatment of HER2-Positive Early Breast Cancer. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
about 11 years ago
1
3
31

BCUTT2 2007 | Treatment of HER2-Positive Advanced Breast Cancer

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Treatment of HER2-Positive Advanced Breast Cancer. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
about 11 years ago
5
2
15

BCUTT2 2007 | Treatment Considerations for Triple-Negative Breast Cancer

BreastCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Treatment Considerations for Triple-Negative Breast Cancer. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
about 11 years ago
9
1
9

SABCS Spin-Off | 06 - Burstein

Most patients with ER-positive, HER2-negative, node-negative breast cancer should be presented with the option of participating in the TAILORx trial and of having the Oncotype DX assay performed outside of a trial.  
Dr Neil Love
about 11 years ago
13
1
41

SABCS Spin-Off | 06 - Vogel

Outside a protocol setting, carboplatin/docetaxel/trastuzumab followed by trastuzumab for a total duration of one year provides the best potential risk/benefit profile for elderly patients with ER-negative, PR-negative, HER2-positive, multiple node-positive breast cancer with a prior cardiac history.  
Dr Neil Love
about 11 years ago